CCI Approves the Proposed Merger Between Sun Pharma and Ranbaxy Subject to Modification https://www.taxtmi.com/news?id=13668 The Competition Commission authorised the Sun Pharma-Ranbaxy combination on the condition that the parties carry out the divestiture of specified products in seven relevant formulation markets and that the merger shall not take effect until those divestitures are implemented, addressing assessed concentration, pipeline-product and potential vertical foreclosure concerns through a modification under the Competition Act, 2002. en-us Tue, 09 Dec 2014 11:52:55 +0530 Tue, 09 Dec 2014 11:52:55 +0530 TaxTMI RSS Generator CCI Approves the Proposed Merger Between Sun Pharma and Ranbaxy Subject to Modification https://www.taxtmi.com/news?id=13668 The Competition Commission authorised the Sun Pharma-Ranbaxy combination on the condition that the parties carry out the divestiture of specified products in seven relevant formulation markets and that the merger shall not take effect until those divestitures are implemented, addressing assessed concentration, pipeline-product and potential vertical foreclosure concerns through a modification under the Competition Act, 2002. News - Tue, 09 Dec 2014 11:52:55 +0530 https://www.taxtmi.com/news?id=13668